Austin Charles's most recent trade in Marinus Pharmaceuticals Inc was a trade of 10,450 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marinus Pharmaceuticals Inc | Charles Austin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 10,450 | 10,450 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Charles Austin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 2,300 | 12,177 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Austin Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Charles Austin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 4,600 | 9,877 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Charles Austin | Director | Sale of securities on an exchange or to another person at price $ 6.49 per share. | 06 Feb 2023 | 1,073 | 5,277 (0%) | 0% | 6.5 | 6,964 | Common Stock |
| Marinus Pharmaceuticals Inc | Charles Austin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 16,200 | 16,200 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Charles Austin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 3,600 | 6,350 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Charles Austin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 12,375 | 12,375 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Charles Austin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 2,750 | 2,750 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Charles Austin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 16,500 | 16,500 | - | - | Stock option (right to buy) |